{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T02:46:55Z","timestamp":1761101215404},"reference-count":35,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T00:00:00Z","timestamp":1383091200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,10,30]],"date-time":"2013-10-30T00:00:00Z","timestamp":1383091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"name":"Sonja-Wasowicz-Stiftung"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1002\/pbc.24827","type":"journal-article","created":{"date-parts":[[2013,10,31]],"date-time":"2013-10-31T09:51:20Z","timestamp":1383213080000},"page":"306-311","source":"Crossref","is-referenced-by-count":4,"title":["Evaluation of effects of busulfan and DMA on SOS in pediatric stem cell recipients"],"prefix":"10.1002","volume":"61","author":[{"given":"Kornelius","family":"Kerl","sequence":"first","affiliation":[{"name":"Department of Pediatric Hematology and Oncology; University Childrens Hospital M\u00fcnster; Muenster Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Diestelhorst","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical and Medical Chemistry-Clinical Pharmacy; University M\u00fcnster; Muenster Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imke","family":"Bartelink","sequence":"additional","affiliation":[{"name":"Department of Bioengineering and Therapeutic Science; University of San Francisco; San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Boelens","sequence":"additional","affiliation":[{"name":"University Medical Center Utrecht; Department of Pediatrics, Stem Cell Transplantation-Unit; Utrecht The Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam N.","family":"Trame","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics; Center for Pharmacometrics and Systems Pharmacology, University of Florida at Lake Nona; Orlando"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Boos","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology; University Childrens Hospital M\u00fcnster; Muenster Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"Hempel","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology and Oncology; University Childrens Hospital M\u00fcnster; Muenster Germany"},{"name":"Department of Pharmaceutical and Medical Chemistry-Clinical Pharmacy; University M\u00fcnster; Muenster Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,10,30]]},"reference":[{"key":"10.1002\/pbc.24827-BIB0001|pbc24827-cit-0001","doi-asserted-by":"crossref","DOI":"10.1007\/s00280-013-2284-9","article-title":"Population pharmacokinetics of dimethylacetamide in children during standard and once-daily IV busulfan administration","author":"Trame","year":"2013","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/pbc.24827-BIB0002|pbc24827-cit-0002","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198312013092202","article-title":"Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide","volume":"309","author":"Santos","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24827-BIB0003|pbc24827-cit-0003","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V70.5.1382.1382","article-title":"Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen","volume":"70","author":"Tutschka","year":"1987","journal-title":"Blood"},{"key":"10.1002\/pbc.24827-BIB0004|pbc24827-cit-0004","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V75.8.1723.1723","article-title":"Busulfan disposition in children","volume":"75","author":"Grochow","year":"1990","journal-title":"Blood"},{"key":"10.1002\/pbc.24827-BIB0005|pbc24827-cit-0005","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood.V84.7.2144.2144","article-title":"Busulfan bioavailability","volume":"84","author":"Hassan","year":"1994","journal-title":"Blood"},{"key":"10.1002\/pbc.24827-BIB0006|pbc24827-cit-0006","first-page":"843","article-title":"Busulphan kinetics and limited sampling model in children with leukemia and inherited disorders","volume":"18","author":"Hassan","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0007|pbc24827-cit-0007","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00688324","article-title":"Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation","volume":"37","author":"Vassal","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/pbc.24827-BIB0008|pbc24827-cit-0008","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/bmt.2009.143","article-title":"Influence of GST gene polymorphisms on busulfan pharmacokinetics in children","volume":"45","author":"Ansari","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0009|pbc24827-cit-0009","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1399-3046.2011.01529.x","article-title":"Therapeutic drug monitoring is essential for intravenous busulfan therapy in pediatric hematopoietic stem cell recipients","volume":"15","author":"Malar","year":"2011","journal-title":"Pediatr Transplant"},{"key":"10.1002\/pbc.24827-BIB0010|pbc24827-cit-0010","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2165\/11598180-000000000-00000","article-title":"Body weight-dependent pharmacokinetics of busulfan in paediatric haematopoietic stem cell transplantation patients: Towards individualized dosing","volume":"51","author":"Bartelink","year":"2012","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/pbc.24827-BIB0011|pbc24827-cit-0011","first-page":"225","article-title":"Association of busulfan area under the curve with veno-occlusive disease following BMT","volume":"17","author":"Dix","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0012|pbc24827-cit-0012","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF00694339","article-title":"Pharmacokinetics of busulfan: Correlation with veno-occlusive disease in patients undergoing bone marrow transplantation","volume":"25","author":"Grochow","year":"1989","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1002\/pbc.24827-BIB0013|pbc24827-cit-0013","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1703612","article-title":"Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"30","author":"McCune","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0014|pbc24827-cit-0014","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1182\/blood.V89.8.3055","article-title":"Marrow transplantation for chronic myeloid leukemia: The influence of plasma busulfan levels on the outcome of transplantation","volume":"89","author":"Slattery","year":"1997","journal-title":"Blood"},{"key":"10.1002\/pbc.24827-BIB0015|pbc24827-cit-0015","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.1158\/1078-0432.CCR-11-0074","article-title":"Population pharmacokinetics of busulfan in children: Increased evidence for body surface area and allometric body weight dosing of busulfan in children","volume":"17","author":"Trame","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1002\/pbc.24827-BIB0016|pbc24827-cit-0016","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2165\/00003088-199937060-00004","article-title":"Cytochrome P450 3A: Ontogeny and drug disposition","volume":"37","author":"de Wildt","year":"1999","journal-title":"Clin Pharmacokinet"},{"key":"10.1002\/pbc.24827-BIB0017|pbc24827-cit-0017","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0041-008X(72)90190-1","article-title":"The metabolism of dimethylformamide and dimethylacetamide","volume":"23","author":"Barnes","year":"1972","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1002\/pbc.24827-BIB0018|pbc24827-cit-0018","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/01480548608998272","article-title":"Acute and subchronic toxicity of dimethylformamide and dimethylacetamide following various routes of administration","volume":"9","author":"Kennedy","year":"1986","journal-title":"Drug Chem Toxicol"},{"key":"10.1002\/pbc.24827-BIB0019|pbc24827-cit-0019","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.bbmt.2008.11.022","article-title":"Association between busulfan exposure and outcome in children receiving intravenous busulfan before hematologic stem cell transplantation","volume":"15","author":"Bartelink","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0020|pbc24827-cit-0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00001813-200503000-00014","article-title":"Toxicity and pharmacokinetics of i.v. busulfan in children before stem cell transplantation","volume":"16","author":"Oechtering","year":"2005","journal-title":"Anticancer Drugs"},{"key":"10.1002\/pbc.24827-BIB0021|pbc24827-cit-0021","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/47.8.1437","article-title":"Sensitive and rapid quantification of busulfan in small plasma volumes by liquid chromatography-electrospray mass spectrometry","volume":"47","author":"Murdter","year":"2001","journal-title":"Clin Chem"},{"key":"10.1002\/pbc.24827-BIB0022|pbc24827-cit-0022","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1200\/JCO.2006.08.8807","article-title":"Cytotoxicity of dimethylacetamide and pharmacokinetics in children receiving intravenous busulfan","volume":"25","author":"Hempel","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1002\/pbc.24827-BIB0023|pbc24827-cit-0023","first-page":"53","article-title":"Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: Incidence, clinical course and outcome","volume":"3","author":"Brugieres","year":"1988","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0024|pbc24827-cit-0024","first-page":"197","article-title":"Hepatic veno-occlusive disease-Liver toxicity syndrome after bone marrow transplantation","volume":"10","author":"Shulman","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0025|pbc24827-cit-0025","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1083-8791(00)70064-4","article-title":"Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy: A phase I study","volume":"6","author":"Andersson","year":"2000","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0026|pbc24827-cit-0026","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.bmt.1701322","article-title":"Pharmacokinetics of intravenous busulfan and evaluation of the bioavailability of the oral formulation in conditioning for haematopoietic stem cell transplantation","volume":"22","author":"Schuler","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0027|pbc24827-cit-0027","doi-asserted-by":"crossref","first-page":"881","DOI":"10.7326\/0003-4819-112-11-881_1","article-title":"Busulfan and veno-occlusive disease of the liver","volume":"112","author":"Vassal","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1002\/pbc.24827-BIB0028|pbc24827-cit-0028","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/pbc.22959","article-title":"Weight-based strategy of dose administration in children using intravenous busulfan: Clinical and pharmacokinetic results","volume":"58","author":"Michel","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.24827-BIB0029|pbc24827-cit-0029","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/sj.clpt.6100168","article-title":"Elevated plasma ferritin and busulfan pharmacodynamics during high-dose chemotherapy regimens in children with malignant solid tumors","volume":"82","author":"Bouligand","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/pbc.24827-BIB0030|pbc24827-cit-0030","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1067\/mcp.2002.124518","article-title":"Genetic polymorphisms of glutathione S-transferase A1, the major glutathione S-transferase in human liver: Consequences for enzyme expression and busulfan conjugation","volume":"71","author":"Bredschneider","year":"2002","journal-title":"Clin Pharmacol Ther"},{"key":"10.1002\/pbc.24827-BIB0031|pbc24827-cit-0031","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.bbmt.2010.12.708","article-title":"Influence of GST gene polymorphisms on the clearance of intravenous busulfan in adult patients undergoing hematopoietic cell transplantation","volume":"17","author":"Kim","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1002\/pbc.24827-BIB0032|pbc24827-cit-0032","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2003-11-3778","article-title":"Glutathione S-transferase M1 polymorphism: A risk factor for hepatic venoocclusive disease in bone marrow transplantation","volume":"104","author":"Srivastava","year":"2004","journal-title":"Blood"},{"key":"10.1002\/pbc.24827-BIB0033|pbc24827-cit-0033","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/FTD.0b013e3181817428","article-title":"Glutathione S-transferase polymorphisms are not associated with population pharmacokinetic parameters of busulfan in pediatric patients","volume":"30","author":"Zwaveling","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1002\/pbc.24827-BIB0034|pbc24827-cit-0034","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.leukres.2006.07.005","article-title":"Gemtuzumab ozogamicin-associated sinusoidal obstructive syndrome (SOS): An overview from the research on adverse drug events and reports (RADAR) project","volume":"31","author":"McKoy","year":"2007","journal-title":"Leuk Res"},{"key":"10.1002\/pbc.24827-BIB0035|pbc24827-cit-0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1177\/096032719301200206","article-title":"Toxicokinetics of dimethylacetamide (DMAc) in rat isolated perfused liver","volume":"12","author":"Palmen","year":"1993","journal-title":"Hum Exp Toxicol"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24827","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24827","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pbc.24827\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T04:25:42Z","timestamp":1716092742000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.24827"}},"subtitle":["Busulfan and DMA in Pediatric SOS"],"short-title":[],"issued":{"date-parts":[[2013,10,30]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.24827","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10,30]]}}}